Salvicine

N/A

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameSalvicine
Drug Alias Name沙尔威辛
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A